Anti-diabetogenic effect of the human amylin analogue, pramlintide, in Type 1 diabetes is not mediated by GLP-1

B Ahrén, N Adner, J Svartberg, E Petrella, Jens Juul Holst, M K Gutniak

1 Citation (Scopus)
Original languageEnglish
JournalDiabetic Medicine
Volume19
Issue number9
Pages (from-to)790-2
Number of pages3
ISSN0742-3071
Publication statusPublished - Sept 2002

Keywords

  • Adult
  • Amyloid
  • Blood Glucose
  • Diabetes Mellitus, Type 1
  • Female
  • Glucagon
  • Glucagon-Like Peptide 1
  • Humans
  • Hyperglycemia
  • Hypoglycemic Agents
  • Islet Amyloid Polypeptide
  • Male
  • Peptide Fragments
  • Protein Precursors

Cite this